Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
HERTFORDSHIRE, United Kingdom, Dec. 7, 2012 /PRNewswire-iReach/ -- Artemis Diagnostics, a developer of innovative imaging technologies for cancer surgery, announced today that the company has been awarded two Smart grants from the Technology Strategy Board, the UK's innovation agency. The two grants, totaling more than £120,000 (US$ 193,000), provide funding for the company to develop its imaging devices for clinical trials and to undertake market research in the US and UK.
Dr David Tuch, CEO of Artemis Diagnostics, commented, "We are pleased the Technology Strategy Board has selected Artemis Diagnostics to receive funding for our product development and market research. The Smart scheme is highly competitive and these awards provide further affirmation of the company's technology and the tremendous need for improved tools to detect cancer during surgery. We believe our molecular imaging technology will provide a significant advance in precision-guided surgery. We look forward to working with our surgeon collaborators to bring our technology into clinical trials."
About the Technology Strategy Board
The Technology Strategy Board is the UK's innovation agency. Its goal is to accelerate economic growth by stimulating and supporting business-led innovation. Sponsored by the Department for Business, Innovation and Skills (BIS), the Technology Strategy Board brings together business, research and the public sector, supporting and accelerating the development of innovative products and services to meet market needs, tackle major societal challenges and help build the future economy. For more information please visit www.innovateuk.org.
About the Smart scheme
Managed by the Technology Strategy Board, the Smart scheme offers funding to small and medium-sized enterprises (SMEs) to engage in R&D projects in the strategically important areas of science, engineering and technology